ESC 365 - Prospective validation of the ARC HBR trade off model in the all comer PIONEER IV trial

ESC Professional Premium Access

Prospective validation of the ARC HBR trade off model in the all comer PIONEER IV trial

Session: All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics

Topic: Outcome

Speaker: Doctor T. Tsai (Taipei, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tsungying Tsai

Taipei (Taiwan)

0 follower

9 more presentations in this session

Examining prognostic scores for short-term major adverse cardiovascular events prediction following primary PCI: a comparative analysis

Speaker: Doctor U. Safdar (Karachi, PK)

Both fibrosis-4 index and fibrosis-5 index can predict the prognosis of patients after percutaneous coronary intervention

Speaker: Doctor T. Gu (Tianjin, CN)

Very short-term effects of single dose of proprotein convertase subtilisin kexin 9 inhibitor therapy before percutaneous coronary intervention

Speaker: Doctor T. Kataoka (Fukui, JP)

Optimizing elective high-risk PCI with ECMO support: the value of completely percutaneous use of VA-ECMO

Speaker: Mr A. Griffioen (Nijmegen, NL)

Impact of moderate to severe anemia on clinical outcomes in patients with atrial fibrillation and coronary artery disease requiring percutaneous coronary intervention

Speaker: Miss K. Abe (Chiba, JP)

Access the full session

All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics

Speakers: Doctor T. Tsai, Doctor U. Safdar, Doctor T. Gu, Doctor T. Kataoka, Mr A. Griffioen...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources